Rapid Dose Therapeutics Corp.

Rapid Dose Therapeutics Corp. Share · CA75339A1012 (OTC) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Rapid Dose Therapeutics Corp.
No Price
Closing Price OTC 30.04.2026: 0,09 USD
01.05.2026 14:01
Current Prices from Rapid Dose Therapeutics Corp.
ExchangeTickerCurrencyLast TradePriceDaily Change
XCNQ: CSE LISTED
CSE LISTED
DOSE.CN
CAD
01.05.2026 14:01
0,10 CAD
0,005 CAD
+5,26 %
OTC: UTC
UTC
RDTCF
USD
30.04.2026 20:00
0,09 USD
0,00 USD
Share Float & Liquidity
Free Float 86,75 %
Shares Float 114,41 M
Shares Outstanding 131,89 M
Company Profile for Rapid Dose Therapeutics Corp. Share
Rapid Dose Therapeutics Corp., a life sciences company, provides drug delivery technologies designed to enhance outcomes and quality of lives in Canada. The company offers QuickStrip/PharmaStrip, an oral fast-dissolving drug delivery system to rapidly release active ingredients into the blood stream, such as pharmaceuticals, emulsified oils, and over-the-counter medicines; QuickStrip energy to deliver energizing caffeine; QuickStrip B12 to deliver vitamin B12 in the system; and QuickStrip sleep that delivers melatonin in the system. The company also provides product innovation, production, and consultation services to the nutraceutical, cannabis healthcare, and pharmaceutical manufacturing industries. It has a research partnership program with McMaster University for developing biopolymer compositions that can offer enhanced drug delivery performance when formulated in oral dissolvable thin films, as well as for developing orally delivered vaccine candidate for COVID-19. Rapid Dose Therapeutics Corp. is based in Burlington, Canada.

Company Data

Name Rapid Dose Therapeutics Corp.
Company Rapid Dose Therapeutics Corp.
Website https://www.rapid-dose.com
Primary Exchange OTC UTC
ISIN CA75339A1012
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mark Andrew Upsdell
Market Capitalization 12 Mio
Country Canada
Currency USD
Employees -
Address 1121 Walkers Line, L7N 2G4 Burlington
IPO Date 2010-02-10

Stock Splits

Date Split
16.02.2018 1:5

Ticker Symbols

Name Symbol
Over The Counter RDTCF
CSE LISTED DOSE.CN
More Shares
Investors who hold Rapid Dose Therapeutics Corp. also have the following shares in their portfolio:
CG PWR+INDL S GDR S/5
CG PWR+INDL S GDR S/5 Depository Receipt
DZ BK CAP.FDG I 03/UND.
DZ BK CAP.FDG I 03/UND. Bond